|Subject Area||Biochemistry, Genetics and Molecular Biology, Medicine|
|Subject Category||Cancer Research, Oncology|
|Publisher||American Association for Cancer Research|
|Scope||Clinical Cancer Research, is a journal of the American Association for Cancer Research whose focus is to publish innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. Clinical Cancer Research is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. The journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. (source)|
Q1 (green) means highest values and Q4 (red) lowest values
The SJR indicator measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.
Evolution of Citations per Document to a journal's published documents during the two, three and four previous years. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.
Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Evolution of the number of total cites per document and external cites per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years.
International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country.
Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows.
Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.